Purdue Pharma Files for Bankruptcy

HeadlineSep 16, 2019

Purdue Pharma filed for bankruptcy Sunday after reaching a tentative settlement last week with a number of state, local and tribal governments over the company’s role in fueling the U.S. opioid crisis. Under the proposed deal, the Sackler family, which owns Purdue, would personally pay $3 billion in cash, plus another $1.5 billion after the pending sale of a subsidiary company is completed. Many plaintiffs have opposed the deal, which would see the Sacklers remain billionaires and admit to no wrongdoing.

New York Attorney General Letitia James has accused Purdue of “lowballing victims” in the settlement, after revealing her office found at least $1 billion in Sackler wire transfers, including through Swiss bank accounts. New York is waiting on financial disclosures from an additional 32 sources, which could further validate claims that the Sacklers are shielding their extreme wealth in investments and foreign institutions.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Up arrowTop